Data / Form D filings / ROC Holdings SPV III, LP
ROC Holdings SPV III, LP: Form D filing
ROC Holdings SPV III, LP, a biotechnology company in Washington, DC, filed a Form D with the SEC in 2026. The latest, on June 26, 2026, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1630 COLUMBIA ROAD NW, APT 418, Washington, DC, 20009
- Phone
- (312) 307-0573
- Industry
- Biotechnology
- Entity type
- Limited Partnership
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2142302
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Smith | Director | Director, GP and Investment Manager of Issuer |
| James Dahlman | Director |
Other biotechnology companies in District of Columbia that filed recently
- OptoVista Holdings, LLC $3.7 million · Sep 25, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ROC Holdings SPV III, LP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.